ASPEK- PARMA MEDIKAL, ZAO, Udmurt Republic

Economic indicators

Net loss (RAS) of ASPEK- PARMA MEDIKAL, ZAO increased 4.49 times to 1.49 million RUB from 331.00 thousand RUB over 2020, the company informed.

Revenue decreased in the accounting period by 49.93% to 60.62 million RUB from 121.08 million RUB in 2020; cost of goods sold decreased by 49.66% to 45.14 million RUB from 89.67 million RUB; sales loss grew 6.20 times to 6.37 million RUB from 1.03 million RUB.

Net loss (RAS) of ASPEK- PARMA MEDIKAL, ZAO dropped over 2020 32.56 times to 331.00 thousand RUB from 10.78 million RUB KAgent.Entities.Balance, the company informed.

Revenue decreased in the accounting period 2.33 times to 121.08 million RUB from 282.35 million RUB in 2019; cost of goods sold decreased 2.37 times to 89.67 million RUB from 212.43 million RUB; sales loss decreased 6.29 times to 1.03 million RUB from 6.46 million RUB.

Net loss (RAS) of ASPEK- PARMA MEDIKAL, ZAO increased 2.01 times to 10.78 million RUB from 5.36 million RUB over 2018, the company informed.

Revenue decreased in the accounting period by 5.75% to 282.35 million RUB from 299.56 million RUB in 2018; cost of goods sold decreased by 4.21% to 212.43 million RUB from 221.76 million RUB; sales loss grew 4.01 times to 6.46 million RUB from 1.61 million RUB.

Net loss (RA) of ASPEK- PARMA MEDIKAL, ZAO made up 5.36 million RUB over 2018 compared to net profit of 1.40 million RUB over 2017, the company informed.

Revenue decreased in the accounting period by 7.83% to 299.56 million RUB from 325.03 million RUB in 2017; cost of goods sold decreased by 7.59% to 221.76 million RUB from 239.97 million RUB; sales loss made up 1.61 million RUB compared to sales profit of 5.65 million RUB.

Net profit (RAS) of ASPEK- PARMA MEDIKAL, ZAO made up 1.40 million RUB over 2017 compared to net loss of 9.38 million RUB over 2016, the company informed.

Revenue decreased in the accounting period by 0.92% to 325.03 million RUB from 328.03 million RUB in 2016; cost of goods sold decreased by 1.45% to 239.97 million RUB from 243.49 million RUB; sales profit made up 5.65 million RUB compared to sales loss of 4.62 million RUB.

Net loss (RA) of ASPEK- PARMA MEDIKAL, ZAO made up 9.38 million RUB over 2016 compared to net profit of 4.28 million RUB over 2015, the company informed.

Revenue increased in the accounting period by 3.87% to 328.03 million RUB from 315.81 million RUB over 2015; cost of goods sold grew by 5.14% to 243.49 million RUB from 231.59 million RUB; sales loss made up 4.62 million RUB compared to sales profit of 9.14 million RUB.

Net profit (RAS) of ASPEK- Parma Medikal, ZAO dropped in 2014 5.37 times to 1.01 million RUB from 5.43 million RUB over the same period in 2013, the company informed.

Revenue increased in the accounting period by 16.69% to 270.84 million RUB from 232.11 million RUB over 2013; cost of goods sold grew by 17.42% to 199.26 million RUB from 169.70 million RUB; sales profit fell 2.13 times to 4.18 million RUB from 8.88 million RUB.

Net profit (RAS) of ASPEK- Parma Medikal, ZAO dropped in 2013 by 41.34% to 5.43 million RUB from 9.25 million RUB over the same period in 2012, the company informed.

Revenue remained in the accounting period at the same level and made up 232.11 million RUB compared to 232.34 million RUB 232.34 million RUB; cost of goods sold decreased by 0.51% to 169.70 million RUB from 170.57 million RUB; sales profit fell by 30.83% to 8.88 million RUB from 12.84 million RUB.

Net profit (RAS) of ASPEHK- Parma Medikal, ZAO grew over 2012 1.98 times to 9.25 million RUB from 4.66 million RUB over 2011, the company informed.

Revenue increased in the accounting period by 37.58% to 232.34 million RUB from 168.87 million RUB over 2011; cost of goods sold grew by 35.70% to 219.50 million RUB from 161.75 million RUB.

Companies in the region

• TEKHNOSERVIS
• PK SEMPL
• DEYSTVIE
• AO "MAYAK"
• AGROPROMYSHLENNOE OB'EDINENIE KOLOS